Leqvio - direct healthcare professional communication (DHPC)

inclisiran

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Leqvio (inclisiran) 284 mg solution for injection in pre-filled syringe: Important information regarding instructions for use before injection

Key facts

• Medicine name:
  Leqvio
• Active substance:
  inclisiran
• Therapeutic area (MeSH):
  • Hypercholesterolemia
  • Dyslipidemias
• Regulatory outcome:
  Maintenance
• DHPC type:
  Quality defect
• Human ATC codes:
  C10AX
• Dissemination date:
  21/12/2023